West Pharmaceutical Services forward PE WST

Share price divided by analysts' consensus earnings for the next twelve months, since 1994.

Today, Oct 23, 2026: 42.2×
10-year median: 41.7×
Against its 10-year history: 51st; percentile: 0 is its lowest day, 100 its highest
10-year range: 28.6× to 65.1×
Peer median: 20.8×

West Pharmaceutical Services' forward PE is 42.2× as of Oct 23, 2026.

That is above its ten-year median of 41.7×, close to the middle of its last ten years.

Over that time it ranged from 28.6× in Mar 2026 to 65.1× in Feb 2024.

The median for 10 medical instruments and supplies stocks of a similar size is 20.8×.

Forward PE over time

median 41.7×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	42.2×	28.6×	42.2×
2025	35.2×	30.7×	56.2×
2024	54.3×	47.8×	65.1×
2023	55.9×	34.1×	61.3×
2022	34.5×	31.6×	53.3×
2021	56.1×	38.1×	57.7×
2020	46.5×	33.9×	56.4×
2019	43.8×	35.1×	47.4×
2018	34.4×	31.4×	45.2×
2017	38.5×	33.6×	40.4×
2016	36.9×	27.1×	36.9×
2015	29.8×	28.5×	34.9×
2014	32.3×	23.8×	32.7×
2013	29.5×	19.8×	30.1×
2012	19.5×	17.1×	21.7×
2011	17.1×	16.0×	19.6×
2010	17.3×	14.6×	22.4×
2009	19.2×	15.2×	20.1×
2008	19.3×	16.7×	27.8×
2007	18.4×	16.9×	24.4×

Against its peers

Companies in Medical - Instruments & Supplies nearest West Pharmaceutical Services' size, closest first, today.

Company	Forward PE
WSTWest Pharmaceutical Services	42.2×
RMDResMed	20.8×
MDLNMedline	23.2×
SOLVSolventum	n/m
BDXBecton, Dickinson and	15.1×
PENPenumbra	n/m
COOCooper Companies	n/m
ALGNAlign Technology	n/m
GMEDGlobus Medical	n/m
PODDInsulet	n/m
MSAMSA Safety	n/m
Peer median	20.8×

Where West Pharmaceutical Services ranks

#48of 51Healthcare stocks with the lowest forward PE

What the forward PE tells you

Price divided by what analysts expect the company to earn over the next twelve months. It answers "what am I paying for next year" instead of last year.

Estimates are opinions. When forward PE is far below trailing PE, analysts expect a big jump in earnings. If that jump slips, the stock was not as cheap as it looked.

More on West Pharmaceutical Services

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.